Advertisement

Percutaneous Image-guided Core Needle Biopsy for Upper Tract Urothelial Carcinoma

Published:October 23, 2019DOI:https://doi.org/10.1016/j.urology.2019.10.005

      Abstract

      OBJECTIVE

      To better understand the safety and diagnostic yield of percutaneous core-needle biopsy (PCNB) for upper tract urothelial carcinoma (UTUC).

      METHODS

      Of 444 patients undergoing radical nephroureterectomy (RNU) for UTUC between 2009 and 2017 at our institution, 42 who had PCNB prior to RNU were identified for analysis. Endpoints included safety, diagnostic yield, and concordance with RNU pathology. PCNB specimens were deemed histologically concordant with RNU specimens for cases when cytologic evaluation of biopsy specimen and corresponding pathologic evaluation of RNU specimen both made a histologic diagnosis of urothelial carcinoma.

      RESULTS

      Median tumor size was 3.8 cm (1.2-10.2 cm). All lesions arose from the pelvicalyceal system. CT-guidance was utilized in 52% (n = 22), and ultrasound-guidance in 48% (n = 20). Relative to RNU pathology, 95% of PCNBs demonstrated histologic concordance. Histologic grade was provided in 69% (n = 29) of PCNBs, with a 90% (n = 26) concordance with surgical pathology. Grades 1-2 and 3 complications occurred in 14.3% (n = 6) and 2.4% (n = 1), respectively. At a median follow-up of 28.2 months (range, 1.2-97.1 months) after biopsy, no cases of radiographic tract seeding were identified.

      CONCLUSION

      In our cohort of 42 patients undergoing RNU for UTUC, PCNB appeared a safe diagnostic tool with high histologic yield and grade concordance. With greater than 2 years of follow-up, no cases of tract seeding were identified.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rouprêt M
        • Babjuk M
        • Compérat E
        • et al.
        European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 update.
        Eur Urol. 2018; 73: 111-122https://doi.org/10.1016/j.eururo.2017.07.036
        • Seisen T
        • Peyronnet B
        • Dominguez-Escrig JL
        • et al.
        Oncologic outcomes of kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: a systematic review by the EAU non-muscle invasive bladder cancer guidelines panel.
        Eur Urol. 2016; 70: 1052-1068https://doi.org/10.1016/j.eururo.2016.07.014
        • Lughezzani G
        • Burger M
        • Margulis V
        • et al.
        Prognostic Factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.
        Eur Urol. 2012; 62: 100-114https://doi.org/10.1016/j.eururo.2012.02.030
        • Clements T
        • Messer JC
        • Terrell JD
        • et al.
        High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection.
        J Endourol. 2011; 26: 398-402https://doi.org/10.1089/end.2011.0426
        • Smith AK
        • Stephenson AJ
        • Lane BR
        • et al.
        Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management.
        Urology. 2011; 78: 82-86https://doi.org/10.1016/j.urology.2011.02.038
        • Guarnizo E
        • Pavlovich CP
        • Seiba M
        • et al.
        Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach.
        J Urol. 2000; 163: 52-55https://doi.org/10.1016/s0022-5347(05)67970-0
        • Vashistha V
        • Shabsigh A
        • Zynger DL
        Utility and diagnostic accuracy of ureteroscopic biopsy in upper tract urothelial carcinoma.
        Arch Pathol Lab Med. 2013; 137: 400-407https://doi.org/10.5858/arpa.2012-0136-OA
        • Hara I
        • Hara S
        • Miyake H
        • et al.
        Usefulness of Ureteropyeloscopy for diagnosis of upper urinary tract tumors.
        J Endourol. 2001; 15: 601-605https://doi.org/10.1089/089277901750426373
        • Keeley FX
        • Kulp DA
        • Bibbo M
        • et al.
        Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma.
        J Urol. 1997; 157: 33-37https://doi.org/10.1016/S0022-5347(01)65273-X
        • Baard J
        • de Bruin DM
        • Zondervan PJ
        • et al.
        Diagnostic dilemmas in patients with upper tract urothelial carcinoma.
        Nat Rev Urol. 2017; 14: 181-191https://doi.org/10.1038/nrurol.2016.252
        • Haifler M
        • Kutikov A
        Current role of renal biopsy in urologic practice.
        Urol Clin North Am. 2017; 44: 203-211https://doi.org/10.1016/j.ucl.2016.12.006
        • Schwartzmann I
        • Pastore AL
        • Saccà A
        • et al.
        Upper Urinary Tract urothelial carcinoma tumor seeding along percutaneous nephrostomy track: case report and review of the literature.
        Urol Int. 2017; 98: 115-119https://doi.org/10.1159/000444808
        • Soukup V
        • Čapoun O
        • Cohen D
        • et al.
        Prognostic performance and reproducibility of the 1973 and 2004/2016 World Health Organization grading classification systems in non–muscle-invasive bladder cancer: a European Association of Urology non-muscle invasive bladder cancer guidelines panel systematic review.
        Eur Urol. 2017; 72: 801-813https://doi.org/10.1016/j.eururo.2017.04.015
        • Mostofi FK
        • Sobin LH
        • Torloni H
        • et al.
        Histological Typing of Urinary Bladder Tumours.
        World Health Organization, 1973 (Accessed May 7, 2019)
        • Cutress ML
        • Stewart GD
        • Zakikhani P
        • et al.
        Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
        BJU Int. 2012; 110: 614-628https://doi.org/10.1111/j.1464-410X.2012.11068.x
        • Huang SY
        • Ahrar K
        • Gupta S
        • et al.
        Safety and diagnostic accuracy of percutaneous biopsy in upper tract urothelial carcinoma.
        BJU Int. 2015; 115: 625-632https://doi.org/10.1111/bju.12824
        • Caoili EM
        • Davenport MS
        Role of percutaneous needle biopsy for renal masses.
        Semin Intervent Radiol. 2014; 31: 20-26https://doi.org/10.1055/s-0033-1363839
        • Lohela P
        • Apaja-Sarkkinen M
        Needle tract seeding after use of a fine needle to biopsy a renal tumour.
        Br Med J. 1986; 292: 174
        • Slywotzky C
        • Maya M
        Needle tract seeding of transitional cell carcinoma following fine-needle aspiration of a renal mass.
        Abdom Imaging. 1994; 19: 174-176https://doi.org/10.1007/BF00203498
        • Sharma NK
        • Nicol A
        • Powell CS
        Track infiltration following percutaneous resection of renal pelvic transitional cell carcinoma.
        Br J Urol. 1994; 73: 597-598https://doi.org/10.1111/j.1464-410X.1994.tb07660.x
        • Fuglsig S
        • Krarup T
        Percutaneous nephroscopic resection of renal pelvic tumors.
        Scand J Urol Nephrol. 1995; 172: 15-17
        • Huang A
        • Low RK
        • White Ralph deVere
        Case reports: nephrostomy tract tumor seeding following percutaneous manipulation of a ureteral carcinoma.
        J Urol. 1995; 153: 1041-1042https://doi.org/10.1016/S0022-5347(01)67632-8
        • Sengupta S
        • Harewood L
        Transitional cell carcinoma growing along an indwelling nephrostomy tube track.
        Br J Urol. 1998; 82: 591
        • Shin ES
        • Darcy MD
        • Mutch D
        Metastatic seeding of a percutaneous nephrostomy tract causing cervical carcinoma.
        Am J Roentgenol. 2002; 178: 933-934https://doi.org/10.2214/ajr.178.4.1780933
        • Corvino C
        • Meliani E
        • Masieri L
        • et al.
        Squamous cell carcinoma of the renal pelvis: nephrostomy tract tumour seeding.
        BJU Int. 2003; 92 (e15-e15)https://doi.org/10.1111/j.1464-410X.2003.02947.x
        • Oefelein MG
        • MacLellan G
        Transitional cell carcinoma recurrence in the nephrostomy tract after percutaneous resection.
        J Urol. 2003; 170 (521-521)https://doi.org/10.1097/01.ju.0000069430.39382.d0
        • Wang SS
        • Ho HC
        • Su CK
        • et al.
        Seeding of malignant renal tumor through a nephrostomy tract.
        J Chin Med Assoc. 2004; 67: 308-310
        • Treuthardt C
        • Danuser H
        • Studer UE
        Tumor seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis.
        Eur Urol. 2004; 46: 442-443https://doi.org/10.1016/j.eururo.2004.01.021
        • Rastinehad AR
        • Ost MC
        • VanderBrink BA
        • et al.
        A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus calmette guérin therapy?.
        Urology. 2009; 73: 27-31https://doi.org/10.1016/j.urology.2008.06.026
        • Sorokin I
        • Welliver RC
        • Elkadi O
        • et al.
        Tumor seeding of percutaneous nephrostomy tract from urothelial carcinoma of the kidney.
        Case Rep Urol. 2013; 2013819470https://doi.org/10.1155/2013/819470